ARMO BioSciences Announces Clinical Data Presentation for Immunotherapy AM0010 at the 12th European … – Yahoo Finance
|
ARMO BioSciences Announces Clinical Data Presentation for Immunotherapy AM0010 at the 12th European …
Yahoo Finance REDWOOD CITY, Calif., April 21, 2017 /PRNewswire/ — ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced that clinical data on the Company's lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) … |
